drug caused significant alteration in venous tone. The results were interpreted as further evidence that salbutamol is a more selective P2 adrenergic receptor stimulant than is isoproterenol.
METHODS
Twenty-five volunteers were studied. In the first group there were 15 patients who had diffuse reversible airways obstruction with a forced vital capacity (FVC), forced expiratory volume in one second (FEV,) and/or a peak expfratoryflow rate (PEFR) below 80 percent of predicted normal.5.6The second group consisted of ten volunteers, including convalescent patients, with various diagnoses, as well as healthy persons. The average age of the first group was 46.8 (17 to 69) years and of the second group, 38.5 (18 to 75) years.
Salbutamoland isoproterenolwere compared in a double blind, crossover fashion. Thirteen volunteers received salbutamol the first test day, while 12 received it on the second day. Each subject lay comfortably on a table equipped with sideboards. After control measurements they received either salbutamol (Ventolin) or isoproterenol (Isuprel-Mistometer) from pressurized aerosol, first one inhalation, then 20 minutes later three inhalations at 20-second intervals. An average inhalation delivers 100 sg of salbutamol, 160 sg of isoproterenol (information on dosage was obtained fro n the Medical Director of Winthrop, Canada). The measurements of blood pressure, heart rate, ECG, blood flow, venous tone and expiratory flow rate were continued for 80 minutes after the first dose was delivered, that is, for 40 minutes after the second dose. After 24 hours, tests were repeated, but each drug was replaced by the other.
Blood pressure was measured on the left forearm by the auscultatory method. The heart rate was continuously recorded during the experiment with a cardiotachometer on a Beckman Dynograph. Blood flow was measured in the right forearm with mercury strain gauge plethysmography;7 before measurement, a cuff on the wrist was inflated to suprasystolic pressure to exclude the hand from the circulation. At the beginning of the experiment a sterile Medicnt cannula was inserted in the superficial vein of the right arm, elevated to heart level, for recording venous tone with the occluded limb technique.8 With this method venous pressure was measured during a sudden arrest of circulation in the forearm. The electrocardiogram was recorded only in lead 2, once in the control period and 1, 10 and 30 minutes after the first drug administration. Blood pressure was recorded every minute for five minutes after each dose and then after every five minutes. Blood flow (at least three determinations, 20 seconds apart) and venous tone were recorded every 10 minutes during the control period and for 60 minutes after the first dose of the drug was given.
The results were analyzed with the Student t test for paired 
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and unpaired samples. All data for each point of time oi observation were separately evaluated with the t test for paired samples (Table 1 ). In these analyses the effect of the drug after both the first and second dose was expressed as the difference in values from the last control observation prior to the first dose, and was compared with the effect of the other drug in the same person. In addition, the t test for unpaired samples was used to determine if the effect of either salbutamol or isoproterenol were significant. When the t test for unpaired samples was used then, too, the effect of the drug for a given time after its administration was expressed as the difference in values from last control observation prior to the first dose being given.
RESULTS
The effect of salbutamol and isoproterenol aerosol on the heart rate, blood pressure, forearm blood flow, arterial resistance, venous tone and peak expiratory flow rate is shown in figures 1 to 6. The first two figures refer to the results in all 25 subjects, figures 3 and 4 to those in the 15 patients with airways obstruction and figures 5 and 6 to those in the 10 patients without airways obstruction. All statistical analyses were done separately for the groups of 25, 15 and 10 subjects. The main effects of the drugs discussed below refer to results in all 25 patients unless otherwise specified.
Heart Rate
Heart rate increased after administration of both drugs, but the increase was greater after treatment with isoproterenol. The mean maximum rate, that is, the fastest heart rate measured in the first five minutes, and standard error (SE) after one inhalation of salbutamol was 90.4±4.3/mm, and after isoproterenol inhalation it was 90.9±4.2/mm. After three inhalations, 93.6±4.4/mm and 97.5±2.8/mm were the respective values. The maximum increase after three inhalations was significantly greater after isoproterenol than after salbutamol (p <0.05). There was a tendency for the heart rate to be raised slightly more after administration of both drugs in patients with diffuse reversible airways obstruction, although control values before the aerosol inhalation were quite similar in the two groups.
Electrocardiogram
In the electrocardiograms we found no consistent alteration after use of either drug and no appearance of arrhythmia.
Blood Pressure
Salbutamol inhalation did not cause any important change in the systolic pressure, while isoproterenol inhalation resulted in a shortlasting slight elevation after both doses. The rise after administration of isoproterenol was significantly more than after treatment with salbutamol at the three time points shown in Figure 1 . Both drugs caused only a minor decrease of the diastolic pressure and, in this respect, there was no significant difference between their effects.
Blood Flow
Blood flow in the forearm was rather stable after isoproterenol inhalation, except for a shortlasting but consistent (p<O.OOl, using t test for unpaired samples) elevation in the first ten minutes after the three inhalations. In contrast, the rise in blood flow 
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after use of salbutamol was more sustained (Fig 2) and remained significant (p<O.Ol, using the t test for unpaired samples) also at the end of the observation.
Arterial Resistance
Arterial resistance in the forearm is given in units calculated from mean arterial pressure (diastolic pressure + 1/3 pulse pressure) divided by forearm blood flow. Salbutamol caused a more sustained reduction in arterial resistance, which was obvious until the end of the test, while the effect of isoproterenol was significant (p<O.OO1) only in the first ten minutes after the second dose. There was a tendency for arterial resistance to be reduced more in the subjects without obstructive lung disease.
Venous Tone
The slight reduction in venous tone of the forearm, more apparent after treatment with isoproterenol than salbutamol, was not significant after use of either drug.
Peak Expiratory Flow Rate
Peak expiratory flow rate increased after treatmejit with both bronchodilators. Using the t test for unpaired samples, this increase was significant (p<O.Ol) for both salbutamol and isoproterenol. The elevation of peak expiratory flow rate was not significantly different whether isoproterenol or salbutamol was given. The rise in expiratory flow rate after administration of both drugs was much greater in patients with airways obstruction.
Side Effects
After salbutamol inhalation, two patients complained of palpitation, and two complained of headache. After isoproterenol was given, six subjects complained of palpitation, and four complained of headache.
DIscussIoN
The salbutamol and isoproterenol used in this study were given by inhalation from a pressurized canister. The amount of drug reaching the bronchial muscle with this form of drug administration is quite uncertain. Nevertheless we decided to give salbutamol in aerosol to allow a proper comparison with isoproterenol, which is used in clinical practice as a bronchodilator and also as an aerosol. Peak expiratory flow rate was measured in the recumbent "Standard error.
position to permit an accurate recording of cardioInterestingly, salbutamol was at least as effective as vascular parameters. Likely these values would have isoproterenol in increasing blood flow and decreasbeen higher if measured, as is customary, in the siting arterial resistance. Forearm blood flow can be ting position.
augmented by higher cardiac output and/or by The action of salbutamol ( Table 2 ) on peak exvasodilation. The first being mediated by / i and the piratory flow rate, blood flow and arterial resistance latter by $2-adrenergic receptors, it is tempting to of the forearm lasted longer than did that of isoproassume that the higher blood flow after administraterenol. Salbutamol, although given in lower dosage, tion of salbutamol is consequent to forearm vasodiwas as effective or more effective than isoproterenol lation, rather than to higher cardiac output. In prein increasing peak expiratory flow rate (Table 3) .
vious experiments we demonstrated that stimulaThis is not surprising in view of several reports tion of ,8 receptors in the human forearm vein reindicating that salbutamol is a more potent and suits in dilation, but only with a large dose of longer-acting bronchodilator than is isoprotereisoproterenol.'6 The lack of significant decrease in venous tone after treatment with isoproterenol or Salbutamol raised heart rate less than did isosalbutamol in these experiments is therefore not surproterenol when given in doses causing similar prising, as only small amounts, if any, of the drug bronchodilation. These results confirm previous would reach the veins. reports34'10'1"3-'5 and suggest that salbutamol This study confirms the difference between salstimulates /3-adrenergic receptors considerably less butamol and isoproterenol in their affinity for /3i-than isoproterenol. The absence of an increase in receptors. It also shows that salbutamol is not withsystolic pressure is suggestive of lack of action on out any effect on these receptors. It seems to us that cardiac force, and leads to a similar explanation.
it is justified to consider salbutamol a step toward the development of a bronchodilator without significalit cardiac effect, but n t as the final solution to this problem.
